Thomas, Mayer & Associés (TMA) advised the biotech firm O&O mdc, an engineering company in ophthalmic medical devices, specialising in Intraoculair Lenses(IOL) and viscoelastic manufacturing, research into new technologies and project development, in the sale of its business to He Vision Group, 何氏眼保健体系, a group of companies specialized in comprehensive eye care system including eye specialists hospital, vision centres, university, research industry centre.
Acquisition of the Anglo-Italian Biotech O&O MDC by the Chinese Group
Cookies are used on this website to improve the user experience and to ensure the efficient functioning of the website.
By using this website, you agree to the use of these cookies please read the Cookies page.
- Recent News: Medical Liability in the Field of Telemedicine
- Recent News: Warshaw Burstein Litigators Win Appeal on Dismissal of Complaint as Time-Barred and Award of Attorneys' Fees
- Recent News: Have a Real Estate Question? Speak With Samuel Marchese at SPONY
- Recent News: DHCR's Annual Rent Registration (ARRO) Portal Now Open for 2026 Filings
- Recent News: New York Law Journal's "Attorneys 'On the Move'" Column Features Steve Mandel, Hon. Jane Pearl and Margaret Brady